Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Charles River Laboratories International, Inc. at the William Blair 38th Annual Growth Stock Conference (Replay)
06/13/18 at 11:00 a.m. ET
Webcast ImageWebcast
Charles River Laboratories International, Inc. at the Jefferies 2018 Global Healthcare Conference (Replay)
06/06/18 at 11:00 a.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
06/04/18Charles River Laboratories to Present at Jefferies and William Blair ConferencesPrinter Friendly Version
05/10/18Charles River Laboratories Announces First-Quarter 2018 Results from Continuing OperationsPrinter Friendly Version
05/03/18Charles River Laboratories Announces Extended Relationship with The Michael J. Fox FoundationPrinter Friendly Version
05/01/18Charles River Laboratories Expands Services for Early Discovery ScreeningPrinter Friendly Version
View More

Upcoming Events

There are currently no events scheduled.
View More

Stock Quote

CRL (common)
Price
$116.21
Change (%)
+ 0.48 (0.41%)
Volume
576,475
Exchange
NYSE
Data as of 06/22/18 4:03 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)